Esophageal cancer is the seventh most common malignancy worldwide, with over 470 000
new cases diagnosed each year. Two distinct histological subtypes predominate, and …

Background Esophageal cancer is one of the 10 most common cancers worldwide and its
incidence is dramatically increasing. Despite some improvements, the current surveillance …

Fluorescence molecular endoscopy (FME) is emerging as a “red-flag” technique with
potential to deliver earlier, faster, and more personalized detection of disease in the …

Objective Improving patient selection and development of biological therapies such as
vedolizumab in IBD requires a thorough understanding of the mechanism of action and …

Background The primary goal of surgery in HNSCC is the complete resection of tumor cells
with maximum preservation of normal tissue. The membrane Hsp70-targeting fluorescence …

(1) Introduction: Near-infrared fluorescence (NIRF) combined with tumour-targeted tracers,
such as bevacizumab-800CW, could aid surgical decision-making. This study explored the …

Purpose: Esophageal cancer carries a poor prognosis with a 5-year overall survival of less
than 20%. Barrett's esophagus increases the risk of esophageal adenocarcinoma. The aim …

Purpose Tumor-targeted positron emission tomography (PET) and fluorescence-guided
surgery (FGS) could address current challenges in pre-and intraoperative imaging of gastric …

Purpose Oesophaegal cancer patients with a clinical complete response (CR) after
neoadjuvant chemoradiotherapy (nCRT) are candidates for an active surveillance strategy …

Purpose Tumor-targeted positron emission tomography (PET) and fluorescence-guided
surgery (FGS) could address current challenges in pre-and intraoperative imaging of gastric …